166 related articles for article (PubMed ID: 30592290)
1. SHCBP1 is a novel target and exhibits tumor‑promoting effects in gastric cancer.
Dong YD; Yuan YL; Yu HB; Tian GJ; Li DY
Oncol Rep; 2019 Mar; 41(3):1649-1657. PubMed ID: 30592290
[TBL] [Abstract][Full Text] [Related]
2. Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.
Peng C; Zhao H; Chen W; Song Y; Wang X; Li J; Qiao Y; Wu D; Ma S; Wang X; Gao C
Oncotarget; 2016 Oct; 7(41):66822-66834. PubMed ID: 27572315
[TBL] [Abstract][Full Text] [Related]
3. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
4. SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis.
Xu N; Wu YP; Yin HB; Chen SH; Li XD; Xue XY; Gou X
J Cancer Res Clin Oncol; 2020 Aug; 146(8):1953-1969. PubMed ID: 32447485
[TBL] [Abstract][Full Text] [Related]
5. Targeting SHCBP1 inhibits cell proliferation in human hepatocellular carcinoma cells.
Tao HC; Wang HX; Dai M; Gu CY; Wang Q; Han ZG; Cai B
Asian Pac J Cancer Prev; 2013; 14(10):5645-50. PubMed ID: 24289556
[TBL] [Abstract][Full Text] [Related]
6. SHCBP1 is over-expressed in breast cancer and is important in the proliferation and apoptosis of the human malignant breast cancer cell line.
Feng W; Li HC; Xu K; Chen YF; Pan LY; Mei Y; Cai H; Jiang YM; Chen T; Feng DX
Gene; 2016 Aug; 587(1):91-7. PubMed ID: 27129942
[TBL] [Abstract][Full Text] [Related]
7. RN181 is a tumour suppressor in gastric cancer by regulation of the ERK/MAPK-cyclin D1/CDK4 pathway.
Wang S; Wang X; Gao Y; Peng Y; Dong N; Xie Q; Zhang X; Wu Y; Li M; Li JL
J Pathol; 2019 Jun; 248(2):204-216. PubMed ID: 30714150
[TBL] [Abstract][Full Text] [Related]
8. SHCBP1 promotes cisplatin induced apoptosis resistance, migration and invasion through activating Wnt pathway.
Zou A; Wu A; Luo M; Zhou C; Lu Y; Yu X
Life Sci; 2019 Oct; 235():116798. PubMed ID: 31472149
[TBL] [Abstract][Full Text] [Related]
9. Biological functions and therapeutic potential of SHCBP1 in human cancer.
Lin Y; Cai H
Biomed Pharmacother; 2023 Apr; 160():114362. PubMed ID: 36739763
[TBL] [Abstract][Full Text] [Related]
10. SOX2-induced upregulation of lncRNA LINC01561 promotes non-small-cell lung carcinoma progression by sponging miR-760 to modulate SHCBP1 expression.
Gao W; Qi CQ; Feng MG; Yang P; Liu L; Sun SH
J Cell Physiol; 2020 Oct; 235(10):6684-6696. PubMed ID: 32003010
[TBL] [Abstract][Full Text] [Related]
11. The Role of Shcbp1 in Signaling and Disease.
Zhang GY; Ma ZJ; Wang L; Sun RF; Jiang XY; Yang XJ; Long B; Ye HL; Zhang SZ; Yu ZY; Shi WG; Jiao ZY
Curr Cancer Drug Targets; 2019; 19(11):854-862. PubMed ID: 31250756
[TBL] [Abstract][Full Text] [Related]
12. Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling.
Fan HN; Zhu MY; Peng SQ; Zhu JS; Zhang J; Qu GQ
Pathol Res Pract; 2020 Feb; 216(2):152795. PubMed ID: 31879047
[TBL] [Abstract][Full Text] [Related]
13. The dynamic role of nucleoprotein SHCBP1 in the cancer cell cycle and its potential as a synergistic target for DNA-damaging agents in cancer therapy.
Zhou M; Duan L; Chen J; Li Y; Yin Z; Song S; Cao Y; Luo P; Hu F; Yang G; Xu J; Liao T; Jin Y
Cell Commun Signal; 2024 Feb; 22(1):131. PubMed ID: 38365687
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SHCBP1 promotes migration and invasion in gliomas by activating the NF-κB signaling pathway.
Zhou Y; Tan Z; Chen K; Wu W; Zhu J; Wu G; Cao L; Zhang X; Zeng X; Li J; Zhang W
Mol Carcinog; 2018 Sep; 57(9):1181-1190. PubMed ID: 29745440
[TBL] [Abstract][Full Text] [Related]
15. Dowregulation of OTX1 attenuates gastric cancer cell proliferation, migration and invasion.
Qin SC; Zhao Z; Sheng JX; Xu XH; Yao J; Lu JJ; Chen B; Zhao GD; Wang XY; Yang YD
Oncol Rep; 2018 Oct; 40(4):1907-1916. PubMed ID: 30066897
[TBL] [Abstract][Full Text] [Related]
16. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
17. Rucaparib inhibits lung adenocarcinoma cell proliferation and migration via the SHCBP1/CDK1 pathway.
Dai Y; Hu C; Zhou H; Liu W; Lai W; Xu R; Liao J; Wang J; Li G; Zhang R
FEBS J; 2023 Dec; 290(24):5720-5743. PubMed ID: 37581853
[TBL] [Abstract][Full Text] [Related]
18. Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer.
Shi W; Zhang G; Ma Z; Li L; Liu M; Qin L; Yu Z; Zhao L; Liu Y; Zhang X; Qin J; Ye H; Jiang X; Zhou H; Sun H; Jiao Z
Nat Commun; 2021 May; 12(1):2812. PubMed ID: 33990570
[TBL] [Abstract][Full Text] [Related]
19. NHE1 is upregulated in gastric cancer and regulates gastric cancer cell proliferation, migration and invasion.
Xie R; Wang H; Jin H; Wen G; Tuo B; Xu J
Oncol Rep; 2017 Mar; 37(3):1451-1460. PubMed ID: 28098891
[TBL] [Abstract][Full Text] [Related]
20. Effects of CDC42 on the proliferation and invasion of gastric cancer cells.
Du DS; Yang XZ; Wang Q; Dai WJ; Kuai WX; Liu YL; Chu D; Tang XJ
Mol Med Rep; 2016 Jan; 13(1):550-4. PubMed ID: 26549550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
